Cambridge Innovation Capital (CIC) is a UK-based private equity firm that focuses on investing in research facilities, infrastructure, and technology companies. CIC typically participates in Series A and Series B funding rounds, supporting ventures with significant growth potential within the UK's robust science and technology ecosystem.

Notable portfolio companies include Nstream, Pretzel Therapeutics, and Seldon, which have collectively raised substantial funding. CIC's investment philosophy centers on leveraging their deep expertise and strategic position to identify and nurture transformative ideas. The firm offers unique value-add services by fostering close collaborations with pioneering entrepreneurs and scientists to drive impactful innovations.